Alter is a senior correspondent at TIME. She covers politics, social movements, and generational change, and hosts TIME's Person of the Week podcast. She is also the author of The Ones We've Been ...

Iran on Friday criticised the continued US sanctions on its trade partners, saying that it will not alter its policy and stated that it created “deep suspicion’ about America. The statement ...

As of the end of March, more than 17,000 MASH patients were actively taking Rezdiffra, compared with more than 11,800 at year-end 2024, according to Madrigal. Rezdiffra’s speed of adding new ...

Weekly semaglutide was found to significantly improve steatohepatitis and fibrosis while enhancing metabolic markers and noninvasive liver health measures in patients with metabolic ...

Boston University sophomore Aiden Celebrini has no regrets over the decision he reached at 16 to maintain his college eligibility by skipping a chance to play for the Western Hockey League's ...

Pakistan has tried to unilaterally alter the Line of Control at least twice after signing the Simla Agreement. Pakistan has claimed it may put the 1972 Simla Agreement "in abeyance" after India's ...

AP Photo/Jeff Roberson "There are players that you can target and acquire who alter the trajectory of a game. There are players that you can target and acquire that alter the trajectory of a ...

To do that, you need to go to an Enchant Alter. There’s one in both the First Sea and the Second Sea. However, the Second Sea’s altar is hidden, so you’ll need our guide to get there smoothly.

These conditions are now called metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH). MASLD involves a buildup of fat in ...

"We're pleased to announce the dosing of first patient in our phase 2 study of DR10624 for the treatment of MASLD/MASH. Patients with MASLD face an increased risk of cardiovascular disease and type 2 ...

The future of treating metabolic dysfunction–associated steatohepatitis (MASH) looks brighter than ever, says Naim Alkhouri, MD, as data emerges on newly developed interventions. By the end of ...

Get Instant Summarized Text (Gist) A bifunctional exosome-based drug delivery system was developed to target metabolic dysfunction-associated steatohepatitis (MASH). By engineering exosomes to ...